Literature DB >> 23518345

Tumor dissemination: an EMT affair.

Jean Paul Thiery1, Chwee Teck Lim.   

Abstract

A recent paper reports that circulating tumor cells (CTCs) from metastatic breast cancer patients exhibit heterogeneous epithelial and mesenchymal phenotypes and that CTCs display higher frequencies of partial or full-blown mesenchymal phenotype than carcinoma cells within primary tumors. Mesenchymal-like CTCs are also elevated in patients who are refractory to therapy.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Year:  2013        PMID: 23518345     DOI: 10.1016/j.ccr.2013.03.004

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  96 in total

1.  Protein disulfide isomerases in the endoplasmic reticulum promote anchorage-independent growth of breast cancer cells.

Authors:  Randi Wise; Sara Duhachek-Muggy; Yue Qi; Michal Zolkiewski; Anna Zolkiewska
Journal:  Breast Cancer Res Treat       Date:  2016-05-09       Impact factor: 4.872

Review 2.  Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors.

Authors:  Nawal Bendris; Bénédicte Lemmers; Jean Marie Blanchard
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Genomic Instability Is Induced by Persistent Proliferation of Cells Undergoing Epithelial-to-Mesenchymal Transition.

Authors:  Valentine Comaills; Lilian Kabeche; Robert Morris; Rémi Buisson; Min Yu; Marissa Wells Madden; Joseph A LiCausi; Myriam Boukhali; Ken Tajima; Shiwei Pan; Nicola Aceto; Srinjoy Sil; Yu Zheng; Tilak Sundaresan; Toshifumi Yae; Nicole Vincent Jordan; David T Miyamoto; David T Ting; Sridhar Ramaswamy; Wilhelm Haas; Lee Zou; Daniel A Haber; Shyamala Maheswaran
Journal:  Cell Rep       Date:  2016-12-06       Impact factor: 9.423

4.  Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer.

Authors:  Megan Agajanian; Farhana Runa; Jonathan A Kelber
Journal:  Biochem Biophys Res Commun       Date:  2015-08-20       Impact factor: 3.575

5.  BVES inhibition triggers epithelial-mesenchymal transition in human hepatocellular carcinoma.

Authors:  Ping Han; Yu Fu; Min Luo; Jiayi He; Jingmei Liu; Jiazhi Liao; Dean Tian; Wei Yan
Journal:  Dig Dis Sci       Date:  2014-01-18       Impact factor: 3.199

Review 6.  Molecular analysis of circulating tumour cells-biology and biomarkers.

Authors:  Matthew G Krebs; Robert L Metcalf; Louise Carter; Ged Brady; Fiona H Blackhall; Caroline Dive
Journal:  Nat Rev Clin Oncol       Date:  2014-01-21       Impact factor: 66.675

7.  Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device.

Authors:  Bee Luan Khoo; Gianluca Grenci; Ying Bena Lim; Soo Chin Lee; Jongyoon Han; Chwee Teck Lim
Journal:  Nat Protoc       Date:  2017-12-07       Impact factor: 13.491

8.  Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells.

Authors:  Kamola Saydaminova; Robert Strauss; Min Xie; Jiri Bartek; Maximilian Richter; Ruan van Rensburg; Charles Drescher; Anja Ehrhardt; Sheng Ding; André Lieber
Journal:  Cancer Biol Ther       Date:  2016-08-30       Impact factor: 4.742

Review 9.  Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer.

Authors:  Sumitra Mohan; Francesca Chemi; Ged Brady
Journal:  Transl Lung Cancer Res       Date:  2017-08

10.  Epithelial Junction Opener Improves Oncolytic Adenovirus Therapy in Mouse Tumor Models.

Authors:  Roma Yumul; Maximilian Richter; Zhuo-Zhuang Lu; Kamola Saydaminova; Hongjie Wang; Chung-Huei Katherine Wang; Darrick Carter; André Lieber
Journal:  Hum Gene Ther       Date:  2016-04       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.